Vaccine Against Atherosclerosis in Patients With Overweight Problems or Obesity
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.
Also called NCT03042741
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 300 participants
- Sponsor
- Immunitor LLC
- Registry
-
NCT03042741
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Mongolia
- Registry status
- Unknown status
Technical summary
Registry record NCT03042741. Randomized; triple masking; primary purpose treatment. Start 2017-02-01 (actual); primary completion 2019-12-18 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Vaccine Against Atherosclerosis in Patients With Overweight Problems or Obesity
- Acronym
- V6
- Condition
- Atherosclerosis
- Intervention (Biological)
- atherosclerosis vaccine
- Intervention (Biological)
- Placebo pills
- Lead sponsor
- Immunitor LLC
- Collaborator
- Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare
Record details
- Record id
cardio:ct-nct03042741- Content hash
c4e3a016037edde7b73d5e3d2d2389e08484f64533c1cfbaa3d4bc2a6de07cca